Cargando…
Relationship of amyloid beta and neurofibrillary tau deposition in Neurodegeneration in Aging Down Syndrome (NiAD) study at baseline
IMPORTANCE: Adults with Down syndrome (DS) are at high‐risk of revealing Alzheimer's disease (AD) pathology, in part due to the triplication of chromosome 21 encoding the amyloid precursor protein. Adults with DS are uniformly affected by AD pathology by their 30′s and have a 70% to 80% chance...
Autores principales: | Tudorascu, DL, Laymon, CM, Zammit, M, Minhas, DS, Anderson, SJ, Ellison, PA, Zaman, S, Ances, BM, Sabbagh, M, Johnson, SC, Mathis, CA, Klunk, WE, Handen, BL, Christian, BT, Cohen, AD |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602678/ https://www.ncbi.nlm.nih.gov/pubmed/33163613 http://dx.doi.org/10.1002/trc2.12096 |
Ejemplares similares
-
Neurofibrillary tau depositions emerge with subthreshold cerebral beta-amyloidosis in down syndrome
por: Zammit, Matthew D., et al.
Publicado: (2021) -
Role of tau deposition in early cognitive decline in Down syndrome
por: Hartley, Sigan L., et al.
Publicado: (2022) -
Amyloid accumulation in Down syndrome measured with amyloid load
por: Zammit, Matthew D., et al.
Publicado: (2020) -
White matter microstructure associations with episodic memory in adults with Down syndrome: a tract-based spatial statistics study
por: Bazydlo, Austin, et al.
Publicado: (2021) -
PET measurement of longitudinal amyloid load identifies the earliest stages of amyloid-beta accumulation during Alzheimer’s disease progression in Down syndrome
por: Zammit, Matthew D., et al.
Publicado: (2021)